Malik Taqdees, Naim Asma, Saeed Asma
Department of Microbiology, University of Karachi, Karachi, Pakistan.
Curr Drug Deliv. 2018;15(3):417-423. doi: 10.2174/1567201815666180101160108.
In the past few years, the use of antimicrobial drugs against a wide range of pathogens has increased significantly. This extensive use of drugs has increased the resistance rate in microbial community widely. Molecular techniques for the detection of resistance are more reliable as compared to the conventional phenotypic method.
The family Enterobacteriaceae is considered to be an important cause of nosocomial infections due to its predominantly active species such as E. coli, Klebsiella and Pseudomonas. These organisms are mainly involved in causing pneumonia, sepsis, post-surgical and urinary tract infections. Resistance against antimicrobial drugs among these isolates is increasing more rapidly all over the world. This study primarily focuses on the resistant isolates of Klebsiella species. The drug resistance in Klebsiella isolates is found to be associated with the production of resistance enzymes such as beta lactamase and extended spectrum beta lactamase (ESBLs) which confer resistance, most specifically against cephalosporins and extended spectrum cephalosporins. Since these enzymes are plasmid mediated, they can also produce resistance against several other antimicrobials. It has been found that among the genus Klebsiella, ESBLs are more prevalent in K. pneumoniae followed by K. oxytoca.
In this study, we estimated the distribution of ESBL producers among Klebsiella species and performed their genetic characterization. A total of 236 gram-negative isolates were collected from different microbiological laboratories, during the period January 2010 till January 2012. Among these gram-negative isolates, 125 were identified as Klebsiella species. After species identification, Kirby Bauer disk diffusion method was used for antimicrobial susceptibility profiling. Furthermore, the phenotypic detection of ESBL producers was performed by double disc synergy and combination disc methods. Resistance genes responsible for the production of beta lactamase and extended spectrum beta lactamase enzymes were detected by Polymerase chain reaction. DNA sequencing was performed by selecting an ESBL producing Klebsiella pneumoniae strain with a positive blaTEM gene.
In this study, we found 48%, 43.2% and 2.4% of SHV, TEM, and CTX-M resistance genes respectively in Klebsiella isolates. The DNA sequence ESBL and blaTEM positive Klebsiella strain showed 94% similarity with Klebsiella pneumoniae KUN5033 blaTEM gene for class A beta-lactamase TEM-198 analyzed by the Basic Local Alignment Search Tool (BLAST).
Since there is an intense need of research in the field of drug resistance for implementing strict antibiotic control policies in hospitals, health care centers, laboratories, etc., the present study is dedicatedly conducted to estimate the drug resistant Klebsiella isolates, specifically the Beta lactamase and Extended Spectrum Beta Lactamase producers, at molecular level.
在过去几年中,针对多种病原体使用抗菌药物的情况显著增加。这种广泛的药物使用在微生物群落中大幅提高了耐药率。与传统的表型方法相比,用于检测耐药性的分子技术更可靠。
肠杆菌科被认为是医院感染的重要原因,因为其主要活跃菌种如大肠杆菌、克雷伯菌和假单胞菌。这些微生物主要引发肺炎、败血症、术后感染和尿路感染。世界各地这些分离株对抗菌药物的耐药性正在更快地增加。本研究主要关注克雷伯菌属的耐药分离株。发现克雷伯菌分离株中的耐药性与β-内酰胺酶和超广谱β-内酰胺酶(ESBLs)等耐药酶的产生有关,这些酶赋予耐药性,最显著的是对头孢菌素和超广谱头孢菌素的耐药性。由于这些酶是质粒介导的,它们也能对其他几种抗菌药物产生耐药性。已发现,在克雷伯菌属中,ESBLs在肺炎克雷伯菌中比产酸克雷伯菌更普遍。
在本研究中,我们估计了克雷伯菌属中ESBL产生菌的分布并进行了基因特征分析。在2010年1月至2012年1月期间,从不同微生物实验室共收集了236株革兰氏阴性分离株。在这些革兰氏阴性分离株中,有125株被鉴定为克雷伯菌属。进行菌种鉴定后,采用 Kirby Bauer 纸片扩散法进行抗菌药物敏感性分析。此外,通过双纸片协同试验和组合纸片法对ESBL产生菌进行表型检测。通过聚合酶链反应检测负责产生β-内酰胺酶和超广谱β-内酰胺酶的耐药基因。通过选择一株blaTEM基因阳性的产ESBL肺炎克雷伯菌菌株进行DNA测序。
在本研究中,我们在克雷伯菌分离株中分别发现了48%、43.2%和2.4%的SHV、TEM和CTX-M耐药基因。通过基本局部比对搜索工具(BLAST)分析,DNA序列ESBL和blaTEM阳性的克雷伯菌菌株与肺炎克雷伯菌KUN5033 blaTEM基因(A类β-内酰胺酶TEM-198)显示出94%的相似性。
由于在耐药领域迫切需要开展研究以在医院、医疗保健中心、实验室等实施严格的抗生素控制政策,本研究专门致力于在分子水平上估计耐药克雷伯菌分离株,特别是β-内酰胺酶和超广谱β-内酰胺酶产生菌。